期刊
MOLECULAR CELL
卷 56, 期 3, 页码 400-413出版社
CELL PRESS
DOI: 10.1016/j.molcel.2014.09.026
关键词
-
资金
- Nora Eccles Treadwell Foundation
- NIH [R01 GM094232, R01 CA157996]
- NIH Developmental Biology Training Grant [5T32HD07491]
- NIH Hematology Training Grant [5T32DK007115-40]
- NCI [P30CA042014]
- NCRR [1S10RR026802-01]
- American Cancer Society-Daiichi Sankyo, Inc. [PF-13-363-01-TBE]
- [CPRIT: RP130272]
Cancer cells are typically subject to profound metabolic alterations, including the Warburg effect wherein cancer cells oxidize a decreased fraction of the pyruvate generated from glycolysis. We show herein that the mitochondrial pyruvate carrier (MPC), composed of the products of the MPC1 and MPC2 genes, modulates fractional pyruvate oxidation. MPC1 is deleted or underexpressed in multiple cancers and correlates with poor prognosis. Cancer cells re-expressing MPC1 and MPC2 display increased mitochondrial pyruvate oxidation, with no changes in cell growth in adherent culture. MPC re-expression exerted profound effects in anchorage-independent growth conditions, however, including impaired colony formation in soft agar, spheroid formation, and xenograft growth. We also observed a decrease in markers of stemness and traced the growth effects of MPC expression to the stem cell compartment. We propose that reduced MPC activity is an important aspect of cancer metabolism, perhaps through altering the maintenance and fate of stem cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据